metformin has been researched along with Salivary Gland Diseases in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Salivary Gland Diseases: Diseases involving the SALIVARY GLANDS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afanas'ev, VV | 1 |
| Striuk, RI | 1 |
| Arutiunian, SE | 1 |
| Eliseeva, LV | 1 |
| Bychkov, RA | 1 |
1 other study available for metformin and Salivary Gland Diseases
| Article | Year |
|---|---|
[Reactive-dystrophic processes in salivary glands (sialoadenoses) running on the background of metabolic syndrome].
Topics: Adolescent; Adult; Aged; Combined Modality Therapy; Diabetes Mellitus, Type 2; Female; Glucose Toler | 2011 |